← Open Payments lookup

MATTHEW MONTGOMERY: Open Payments

NPI 1942549860 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$855 in 36 payments from 11 companies in 2025. Trend: 2023 $792 · 2024 $978 · 2025 $855

Food & beverage: $776Education: $79
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$292
GENZYME CORPORATION6$99
Insmed, Inc.4$93
Novo Nordisk Inc1$81
SANOFI-AVENTIS U.S. LLC1$79
Regeneron Healthcare Solutions, Inc.4$78
GlaxoSmithKline, LLC.3$52
ABBVIE INC.1$25
Merck Sharp & Dohme LLC1$20
3B Medical, Inc.1$20

Products named: DUPIXENT, Arikayce, FARXIGA, NUCALA, TEZSPIRE, DALVANCE, ZERBAXA, LUNA.

Industry payments across AL — which companies pay providers there.